Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator
- PMID: 2523237
Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator
Abstract
Dehydroepiandrosterone (DHEA) is a naturally occurring C19-steroid that is found in the peripheral circulation of mammals, including humans. The feeding of DHEA to rodents has been shown to inhibit chemical carcinogenesis in colon, liver, and lung. Therefore, the effect of DHEA on hepatic enzyme activities that are associated with carcinogen metabolism was assessed. Microsomal NADPH-cytochrome P-450 reductase activity and the content of cytochrome b5 were induced 1.8- and 1.4-fold, respectively, upon feeding male Sprague-Dawley rats a synthetic diet containing 0.45% DHEA (w/w). No significant changes in total content of microsomal cytochrome P-450 or the activities of microsomal NADH-cytochrome b5 reductase and cytosolic or microsomal NAD(P)H-quinone oxidoreductase were noted at day 7 of feeding. Cytosolic glutathione S-transferase activity was decreased to 68% of control activity. Administration of DHEA p.o. or by i.p. injection for 5 days led to the same extent of induction of NADPH-cytochrome P-450 reductase activity. Maximal induction of this flavoprotein reductase was noted between days 3 and 4 of feeding or at a dose of 80-120 mg/kg i.p. A small but statistically significant increase in total microsomal cytochrome P-450 was observed after DHEA administration i.p. Rats fed DHEA had a slower growth rate compared with rats fed control diet, whereas rats treated with DHEA i.p. had growth rates identical to those of controls. The liver weights of rats given DHEA by p.o. or i.p. routes were increased significantly compared to those of control rats. Pair feeding of rats with DHA-containing or control diets served to demonstrate that the levels of induction of hepatic microsomal NADPH-cytochrome P-450 reductase and at least one form of cytochrome P450 (P-450IVA1) were the same as those seen in livers of rats fed DHEA ad libitum. This finding suggested that the induction of the flavoprotein and at least one form of the cytochrome was not due to caloric restriction. The increase in NADPH-cytochrome P-450 reductase content of liver microsomes prepared from rats either fed or treated i.p. with DHEA was also observed by Western blotting techniques. DHEA did not appear to induce any of the major forms of rat liver microsomal cytochrome P-450 that are normally increased by either phenobarbital, beta-naphthoflavone, or dexamethasone pretreatment of rats in vivo. However, the measurement of androstenedione and testosterone metabolism in vitro showed pronounced decreases in the 16 alpha-hydroxylase activities of liver microsomes following DHEA feeding.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone.Mol Pharmacol. 1996 Feb;49(2):276-87. Mol Pharmacol. 1996. PMID: 8632760
-
Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolite in rats.Cancer Res. 1994 Jun 1;54(11):2878-86. Cancer Res. 1994. PMID: 8187072
-
Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.Mol Pharmacol. 1996 Jul;50(1):67-74. Mol Pharmacol. 1996. PMID: 8700121
-
Cytochrome P-450s as toxicogenic catalysts: the influence of dehydroepiandrosterone.Princess Takamatsu Symp. 1990;21:33-44. Princess Takamatsu Symp. 1990. PMID: 2151997 Review.
-
Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator.J Endocrinol. 1996 Sep;150 Suppl:S129-47. J Endocrinol. 1996. PMID: 8943797 Review.
Cited by
-
Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor.Drug Metab Dispos. 2007 Sep;35(9):1495-501. doi: 10.1124/dmd.107.016303. Epub 2007 Jun 25. Drug Metab Dispos. 2007. PMID: 17591676 Free PMC article.
-
An overview of peroxisome proliferator-induced hepatocarcinogenesis.Environ Health Perspect. 1991 Jun;93:205-9. doi: 10.1289/ehp.9193205. Environ Health Perspect. 1991. PMID: 1685443 Free PMC article. Review.
-
Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferators.Mol Pharmacol. 2008 Mar;73(3):968-76. doi: 10.1124/mol.107.036780. Epub 2007 Dec 13. Mol Pharmacol. 2008. PMID: 18079279 Free PMC article.
-
Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor.Mol Cell Endocrinol. 2014 Jul 5;392(1-2):23-36. doi: 10.1016/j.mce.2014.05.007. Epub 2014 May 17. Mol Cell Endocrinol. 2014. PMID: 24845419 Free PMC article.
-
The effects of dehydroepiandrosterone on carcinogenesis, obesity, the immune system, and aging.Lipids. 2000 Mar;35(3):325-31. doi: 10.1007/s11745-000-0529-7. Lipids. 2000. PMID: 10783010 Review.